ArticleJournal of nanobiotechnology2025
Dimensional control of DNA nanostructures enhances cellular uptake and guides tissue-regenerative responses.
Article in Journal of nanobiotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Advances in DNA nanostructures for pathogenic microorganisms.Materials today. Bio · 2026Review
- Synergistic regulation of hDPSC-iPSCs by tetrahedral DNA nanostructures for dentin-pulp complex regeneration.Stem cells translational medicine · 2026Article
- Dynamic DNA Nanomachines for Biosensing and Drug Delivery.Sensors (Basel, Switzerland) · 2026Review
- DNA Nanostructures for siRNA Delivery.Bioconjugate chemistry · 2026Review
- Renal-targeted tFNA-TPP nanoagonist treats acute kidney injury by amplifying mitophagy.Materials today. Bio · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Precise regulation of cellular functions is fundamental for advancing tissue regeneration and drug delivery systems. Structural DNA nanotechnology enables the design of well-defined nanostructures, emerging as a promising platform in these biomedical applications. However, a clear understanding of how the dimensional properties of DNA nanostructures affect cellular uptake and biological responses remains limited. In this study, we constructed three distinct DNA nanostructures: a one-dimensional six-helix bundle (6HB), a two-dimensional three-point star, and a three-dimensional tetrahedron. We systematically evaluated their endocytic efficiency in five representative cell types: endothelial cells, dermal fibroblasts, myoblasts, chondrocytes, and osteoblasts. Among them, the 6HB exhibited the highest cellular uptake, with minimal variability across cell types in both 2D petri dish cultures and 3D multicellular spheroid invasion models. Moreover, DNA nanostructures were found to enhance cell proliferation in fibroblasts and chondrocytes, support chondrocyte phenotype maintenance, and, in the case of the 6HB, promote myoblast differentiation. These findings provide new insights into structure-function relationships in DNA nanomaterials and offer guidance for optimizing DNA-based platforms for drug delivery and regenerative medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.